Two distinct immunopathological profiles in autopsy lungs of COVID-19.
Ronny NienholdYari CianiViktor Hendrik KoelzerAlexandar TzankovJasmin D HaslbauerThomas MenterNathalie SchwabMaurice HenkelAngela FrankVeronika ZsiklaNiels WilliWerner KempfThomas HoylerMattia BarbareschiHolger MochMarkus TolnayGieri CathomasFrancesca DemichelisTobias JuntKirsten D MertzPublished in: Nature communications (2020)
Coronavirus Disease 19 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has grown to a worldwide pandemic with substantial mortality. Immune mediated damage has been proposed as a pathogenic factor, but immune responses in lungs of COVID-19 patients remain poorly characterized. Here we show transcriptomic, histologic and cellular profiles of post mortem COVID-19 (n = 34 tissues from 16 patients) and normal lung tissues (n = 9 tissues from 6 patients). Two distinct immunopathological reaction patterns of lethal COVID-19 are identified. One pattern shows high local expression of interferon stimulated genes (ISGhigh) and cytokines, high viral loads and limited pulmonary damage, the other pattern shows severely damaged lungs, low ISGs (ISGlow), low viral loads and abundant infiltrating activated CD8+ T cells and macrophages. ISGhigh patients die significantly earlier after hospitalization than ISGlow patients. Our study may point to distinct stages of progression of COVID-19 lung disease and highlights the need for peripheral blood biomarkers that inform about patient lung status and guide treatment.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- immune response
- prognostic factors
- gene expression
- type diabetes
- peripheral blood
- poor prognosis
- dna methylation
- dendritic cells
- cardiovascular disease
- patient reported
- binding protein